Schweinfurthin induces ICD without ER stress and caspase activation

Oncoimmunology. 2022 Aug 3;11(1):2104551. doi: 10.1080/2162402X.2022.2104551. eCollection 2022.

Abstract

Our previous study showed that one of the schweinfurthin compounds, 5'-methoxyschweinfurthin G (MeSG), not only enhances the anti-tumor effect of anti-PD1 antibody in the B16F10 murine melanoma model, but also provokes durable, protective anti-tumor immunity. Here we further investigated the mechanisms by which MeSG treatment induces immunogenic cell death (ICD). MeSG induced significant cell surface calreticulin (CRT) exposure in a time and concentration dependent manner as well as increased phagocytosis of tumor cells by dendritic cells in vitro. Interestingly, this CRT exposure differs from the canonical pathway in several aspects. MeSG does not cause ER stress and does not require PERK to induce CRT exposure. Caspase inhibitors partially rescue cells from MeSG-induced apoptosis, but fail to reduce CRT exposure. MeSG does not cause ERp57 exposure and the absence of ERp57 expression does not reduce CRT exposure. Finally, an intact ER to Golgi transport system is required for this phenomenon. These results lend support to the development of the schweinfurthin family as drugs to enhance clinical response to immunotherapy and highlight the need for additional research on the mechanisms of ICD induction.

Keywords: ER stress; Immunogenic Cell Death (ICD); Schweinfurthins; apoptosis; calreticulin (CRT).

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Apoptosis
  • Caspases / pharmacology
  • Cell Death
  • Immunogenic Cell Death*
  • Mice
  • Neoplasms*

Substances

  • Caspases

Grants and funding

This work was funded by a Penn State University Professorship in Medical Oncology, the Miriam Beckner Cancer Research Endowment and a gift from Highmark to the Penn State Cancer Institute.